The National Turkey Federation supports import permit to improve treatment of the contagious respiratory disease.

Substantial enrollment progress in Phase 1b trial of SZN-043 in severe alcohol-associated hepatitis patients with proof-of-concept data expected ...

Privately-held German drugmaker Boehringer Ingelheim and researchers from the Stanley Center for Psychiatric Research at the ...

Danish biotech Gubra announces that Germany’s Boehringer Ingelheim has decided to discontinue the development of the long-acting neuropeptide Y receptor type 2 (NPY2R) agonist BI 1820237 in obesity.

Recent funding rounds in the digital health arena feature digital pathology startup Aignostics, remote care specialists TCC, ...

No. 49 / 2024Zealand Pharma Announces Financial Results for the First Nine Months of 2024Continued strong progress across ...

Dr. Athalye is recognized for his focus on innovative, patient-centric strategies and his commitment to sustainable growth.

A hotel near the Danbury Fair Mall is for sale for $6.25 million, according to a listing from Coldwell Banker Commercial Realty. The 76,000-square-foot Maron Hotel & Suites, at 42 Lake Ave. Ext. in ...

Animal health companies are developing vaccines that improve the breadth and effectiveness of protection against avian ...

Surrozen, Inc. ('Surrozen” or the 'Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today announced ...

Drugs from Eli Lilly and Boehringer Ingelheim grabbed the spotlight at ... The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial ...